share_log

Leerink Partners Maintains Outperform on DexCom, Lowers Price Target to $87

Benzinga ·  Oct 25 21:23  · Ratings

Leerink Partners analyst Mike Kratky maintains DexCom (NASDAQ:DXCM) with a Outperform and lowers the price target from $90 to $87.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment